Echo Therapeutics, Inc. announced that Alan W. Schoenbart, CPA, a senior executive with more than thirty years of financial management experience, joined the company as Chief Financial Officer effective December 29, 2014. Schoenbart joins Echo from Hudson News Distributors, LLC where he most recently served as CFO.
Echo Therapeutics, Inc.
Equities
ECTE
US27876L2060
Advanced Medical Equipment & Technology
1st Jan change | Capi. | |
---|---|---|
+11.35% | 221B | |
+9.87% | 186B | |
+15.24% | 137B | |
+28.06% | 109B | |
-0.42% | 63.09B | |
+15.00% | 52.68B | |
+4.86% | 50.86B | |
+8.92% | 42.53B | |
+7.26% | 37.76B |